🇺🇸 FDA
Patent

US 6613743

Sulfonamide inhibitors of aspartyl protease

expired A61PA61P31/18

Quick answer

US patent 6613743 (Sulfonamide inhibitors of aspartyl protease) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Sep 02 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61P, A61P31/18